WallStreetZenWallStreetZen

NASDAQ: CYCC
Cyclacel Pharmaceuticals Inc Stock Ownership - Who owns Cyclacel Pharmaceuticals?

Insider buying vs selling

Have Cyclacel Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Paul McBarronE. VP Fin CFO COO and Secretary2023-12-211,886$3.32
$6.25kBuy
Spiro George RombotisPresident and CEO2023-12-216,070$3.32
$20.12kBuy

1 of 1

CYCC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYCC insiders and whales buy or sell their stock.

CYCC Shareholders

What type of owners hold Cyclacel Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe212.93%2,806,900$5.39MInsider
Stanley Morgan172.72%2,276,852$4.37MInsider
James E. Flynn105.07%1,385,091$2.66MInsider
Kevin C. Tang32.29%425,700$817.34kInsider
Spiro George Rombotis5.21%68,658$131.82kInsider
Eastern Capital Ltd5.00%65,863$126.46kInsider
Judy Chiao4.40%58,008$111.38kInsider
Lloyd Sems3.91%51,529$98.94kInsider
Kenneth M. Ferguson3.41%44,952$86.31kInsider
Karin L. Walker3.08%40,602$77.96kInsider

1 of 3

CYCC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYCC1.23%98.77%Net Buying
DRMA4.01%95.99%
FWBI0.08%99.92%Net SellingNet Selling
BPTH3.24%96.76%
PCSA19.50%80.50%Net BuyingNet Buying

Cyclacel Pharmaceuticals Stock Ownership FAQ

Who owns Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals (NASDAQ: CYCC) is owned by 7.12% institutional shareholders, 571.08% Cyclacel Pharmaceuticals insiders, and 0.00% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Cyclacel Pharmaceuticals shareholder, owning 2.81M shares representing 212.93% of the company. Austin W. Greenhouse David M. Marxe's Cyclacel Pharmaceuticals shares are currently valued at $5.50M.

If you're new to stock investing, here's how to buy Cyclacel Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.